Stage IV Lymphoepithelioma of the Nasopharynx Completed Phase 1 Trials for Erlotinib (DB00530)

DBCOND0029528 (Stage IV Lymphoepithelioma of the Nasopharynx)Completed1 IdentifierTitlePurposeDrugs
NCT00030498Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionTreatment
NCT00397384Erlotinib Hydrochloride and Cetuximab in Treating Patients With Advanced Gastrointestinal Cancer, Head and Neck Cancer, Non-Small Cell Lung Cancer, or Colorectal CancerTreatment